Serotonin agonists and antagonists in experimental hypertension

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Neuroscience

Background:

• Serotonin (5-hydroxytryptamine; 5-HT) influences cardiovascular activity through central and peripheral actions.
• Central administration of 5-HT can cause either pressor or depressor effects, potentially mediated by 5-HT1A receptors.

Purpose of the Study:

• To investigate the mechanisms by which serotonin affects cardiovascular activity.
• To elucidate the role of different serotonin receptors in blood pressure regulation.
• To understand the antihypertensive actions of ketanserin.

Main Methods:

• Administration of 5-HT centrally and peripherally in animal models (hypertensive and normotensive).
• Evaluation of cardiovascular responses, including blood pressure changes.
• Assessment of receptor affinity and antagonist properties of ketanserin.

Main Results:

• Central 5-HT can induce depressor effects via 5-HT1-like receptors.
• Peripherally, 5-HT mediates vasodilation or vasoconstriction through 5-HT1-like and 5-HT2 receptors, respectively.
• Ketanserin effectively lowers blood pressure, but its action involves more than just 5-HT2 receptor blockade.

Conclusions:

• The antihypertensive effect of ketanserin is likely due to a combination of 5-HT2 receptor blockade, alpha 1-adrenoceptor antagonism, central vasomotor depression, and direct vasodilation.
• Peripheral vascular resistance is not significantly influenced by plasma 5-HT concentrations in hypertension.
• Central mechanisms involving 5-HT1A receptors play a role in blood pressure reduction.